134 related articles for article (PubMed ID: 28852953)
1. Modeling the Transfer of Drug Resistance in Solid Tumors.
Becker M; Levy D
Bull Math Biol; 2017 Oct; 79(10):2394-2412. PubMed ID: 28852953
[TBL] [Abstract][Full Text] [Related]
2. A Model for Transfer of P-Glycoproteins in MCF-7 Breast Cancer Cell Line with Multiple Transfer Rules.
Magal P; Noussair A; Pasquier J; Zongo P; Le Foll F
Bull Math Biol; 2017 Sep; 79(9):2049-2067. PubMed ID: 28721472
[TBL] [Abstract][Full Text] [Related]
3. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
[TBL] [Abstract][Full Text] [Related]
4. Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model.
Pasquier J; Magal P; Boulangé-Lecomte C; Webb G; Le Foll F
Biol Direct; 2011 Jan; 6():5. PubMed ID: 21269489
[TBL] [Abstract][Full Text] [Related]
5. Transfer of Drug Resistance Characteristics Between Cancer Cell Subpopulations: A Study Using Simple Mathematical Models.
Rosa Durán M; Podolski-Renić A; Álvarez-Arenas A; Dinić J; Belmonte-Beitia J; Pešić M; Pérez-García VM
Bull Math Biol; 2016 Jun; 78(6):1218-37. PubMed ID: 27337966
[TBL] [Abstract][Full Text] [Related]
6. Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy.
Cho H; Levy D
Bull Math Biol; 2017 Dec; 79(12):2986-3012. PubMed ID: 29022203
[TBL] [Abstract][Full Text] [Related]
7. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs.
Pesic M; Markovic JZ; Jankovic D; Kanazir S; Markovic ID; Rakic L; Ruzdijic S
J Chemother; 2006 Feb; 18(1):66-73. PubMed ID: 16572896
[TBL] [Abstract][Full Text] [Related]
8. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
Yakisich JS; Venkatadri R; Azad N; Iyer AKV
J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
10. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
11. Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.
Stark M; Assaraf YG
Oncotarget; 2017 Jul; 8(30):49973-49987. PubMed ID: 28637003
[TBL] [Abstract][Full Text] [Related]
12. The impact of cell density and mutations in a model of multidrug resistance in solid tumors.
Greene J; Lavi O; Gottesman MM; Levy D
Bull Math Biol; 2014 Mar; 76(3):627-53. PubMed ID: 24553772
[TBL] [Abstract][Full Text] [Related]
13. Relevance of multidrug resistance in the age of targeted therapy.
Türk D; Szakács G
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870
[TBL] [Abstract][Full Text] [Related]
14. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
15. Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells.
Kopecka J; Porto S; Lusa S; Gazzano E; Salzano G; Giordano A; Desiderio V; Ghigo D; Caraglia M; De Rosa G; Riganti C
Oncotarget; 2015 Oct; 6(31):31461-78. PubMed ID: 26372812
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells.
Abdelfatah SA; Efferth T
Phytomedicine; 2015 Feb; 22(2):308-18. PubMed ID: 25765838
[TBL] [Abstract][Full Text] [Related]
17. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.
Erić S; Kalinić M; Ilić K; Zloh M
SAR QSAR Environ Res; 2014; 25(12):939-66. PubMed ID: 25435255
[TBL] [Abstract][Full Text] [Related]
18. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.
Anreddy N; Patel A; Zhang YK; Wang YJ; Shukla S; Kathawala RJ; Kumar P; Gupta P; Ambudkar SV; Wurpel JN; Chen ZS; Guo H
Oncotarget; 2015 Nov; 6(36):39276-91. PubMed ID: 26515463
[TBL] [Abstract][Full Text] [Related]
19. Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth.
Cho H; Levy D
J Theor Biol; 2018 Jan; 436():120-134. PubMed ID: 29030212
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
Katayama R; Sakashita T; Yanagitani N; Ninomiya H; Horiike A; Friboulet L; Gainor JF; Motoi N; Dobashi A; Sakata S; Tambo Y; Kitazono S; Sato S; Koike S; John Iafrate A; Mino-Kenudson M; Ishikawa Y; Shaw AT; Engelman JA; Takeuchi K; Nishio M; Fujita N
EBioMedicine; 2016 Jan; 3():54-66. PubMed ID: 26870817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
